Dr. David Johnson shared key highlights from the 2024 American College of Gastroenterology (ACG) Annual Scientific Meeting, including promising research and updates in gastroenterology. He discussed potential challenges with video capsule endoscopy in patients on GLP-1 receptor agonists, citing a Mayo Clinic study showing slower gastric transit in these patients. The increasing incidence of young-onset Barrett esophagus also calls for possible re-evaluation of screening guidelines, as young patients with certain risk factors may be at higher risk. Dr. Johnson highlighted new biologic options for eosinophilic esophagitis, like cendakimab, and shared data from a study that found no added benefit to using bezlotoxumab with fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease (IBD).
Keep Reading
Add A Comment